

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microglial cell activation (GO:0001774) | 7.04509354 |
| 2 | negative regulation of granulocyte differentiation (GO:0030853) | 5.54408269 |
| 3 | positive regulation of chemokine secretion (GO:0090197) | 5.44490683 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 5.34565266 |
| 5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.33945612 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.23019217 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.23019217 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.23019217 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.23019217 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.23019217 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.23019217 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21257068 |
| 13 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.80937659 |
| 14 | keratan sulfate catabolic process (GO:0042340) | 4.77251843 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.31257733 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.31257733 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.31257733 |
| 18 | macrophage activation (GO:0042116) | 4.28644012 |
| 19 | regulation of macrophage chemotaxis (GO:0010758) | 4.21965322 |
| 20 | indolalkylamine metabolic process (GO:0006586) | 4.13289749 |
| 21 | regulation of chemokine secretion (GO:0090196) | 3.94665175 |
| 22 | behavioral response to nicotine (GO:0035095) | 3.90777781 |
| 23 | apoptotic cell clearance (GO:0043277) | 3.88610221 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.85603402 |
| 25 | complement activation, alternative pathway (GO:0006957) | 3.85157105 |
| 26 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.83072957 |
| 27 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.79821496 |
| 28 | response to cholesterol (GO:0070723) | 3.77599389 |
| 29 | tryptophan metabolic process (GO:0006568) | 3.73198998 |
| 30 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.71511911 |
| 31 | cellular extravasation (GO:0045123) | 3.70961002 |
| 32 | mannose metabolic process (GO:0006013) | 3.67402198 |
| 33 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.63718602 |
| 34 | phagocytosis, engulfment (GO:0006911) | 3.63593757 |
| 35 | chondroitin sulfate catabolic process (GO:0030207) | 3.57977923 |
| 36 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.55865391 |
| 37 | detection of light stimulus involved in visual perception (GO:0050908) | 3.55865391 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.52000772 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39097152 |
| 40 | response to host immune response (GO:0052572) | 3.39097152 |
| 41 | response to host (GO:0075136) | 3.35705492 |
| 42 | response to host defenses (GO:0052200) | 3.35705492 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35705492 |
| 44 | I-kappaB phosphorylation (GO:0007252) | 3.30392782 |
| 45 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.30369035 |
| 46 | monocyte differentiation (GO:0030224) | 3.27266701 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.24911277 |
| 48 | fucose catabolic process (GO:0019317) | 3.23295027 |
| 49 | L-fucose metabolic process (GO:0042354) | 3.23295027 |
| 50 | L-fucose catabolic process (GO:0042355) | 3.23295027 |
| 51 | indole-containing compound metabolic process (GO:0042430) | 3.19610499 |
| 52 | neuronal action potential (GO:0019228) | 3.19549123 |
| 53 | response to sterol (GO:0036314) | 3.19201203 |
| 54 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.17845503 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17753269 |
| 56 | behavioral response to ethanol (GO:0048149) | 3.16573564 |
| 57 | drug catabolic process (GO:0042737) | 3.14086571 |
| 58 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.13896353 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.13542470 |
| 60 | ketone body metabolic process (GO:1902224) | 3.12868427 |
| 61 | germ cell migration (GO:0008354) | 3.09819322 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09576794 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04623113 |
| 64 | hyaluronan catabolic process (GO:0030214) | 3.03073825 |
| 65 | complement activation (GO:0006956) | 3.02638289 |
| 66 | negative regulation of bone resorption (GO:0045779) | 3.01526699 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 3.01162678 |
| 68 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.01025204 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99466824 |
| 70 | interkinetic nuclear migration (GO:0022027) | 2.98945318 |
| 71 | cAMP catabolic process (GO:0006198) | 2.97829463 |
| 72 | reflex (GO:0060004) | 2.96928182 |
| 73 | neural tube formation (GO:0001841) | 2.95937296 |
| 74 | regulation of complement activation (GO:0030449) | 2.94612224 |
| 75 | positive regulation of B cell differentiation (GO:0045579) | 2.94164937 |
| 76 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.93695711 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.91924632 |
| 78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91599608 |
| 79 | regulation of hippo signaling (GO:0035330) | 2.91508842 |
| 80 | regulation of sarcomere organization (GO:0060297) | 2.90838985 |
| 81 | exogenous drug catabolic process (GO:0042738) | 2.90395843 |
| 82 | purinergic receptor signaling pathway (GO:0035587) | 2.90156100 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 2.88731331 |
| 84 | germinal center formation (GO:0002467) | 2.88667756 |
| 85 | primary amino compound metabolic process (GO:1901160) | 2.88088753 |
| 86 | membrane depolarization during action potential (GO:0086010) | 2.86881556 |
| 87 | cyclooxygenase pathway (GO:0019371) | 2.86288433 |
| 88 | oxidative demethylation (GO:0070989) | 2.86194838 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 2.84546346 |
| 90 | amine catabolic process (GO:0009310) | 2.84546346 |
| 91 | cyclic nucleotide catabolic process (GO:0009214) | 2.83934808 |
| 92 | serotonin metabolic process (GO:0042428) | 2.83046060 |
| 93 | regulation of mononuclear cell migration (GO:0071675) | 2.81469506 |
| 94 | negative regulation of tissue remodeling (GO:0034104) | 2.81382918 |
| 95 | photoreceptor cell maintenance (GO:0045494) | 2.79954568 |
| 96 | pinocytosis (GO:0006907) | 2.78464384 |
| 97 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.78120096 |
| 98 | auditory receptor cell stereocilium organization (GO:0060088) | 2.77383425 |
| 99 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.74968215 |
| 100 | tachykinin receptor signaling pathway (GO:0007217) | 2.73839708 |
| 101 | import into cell (GO:0098657) | 2.73767376 |
| 102 | dopamine transport (GO:0015872) | 2.73067552 |
| 103 | inner ear receptor stereocilium organization (GO:0060122) | 2.70662175 |
| 104 | regulation of protein activation cascade (GO:2000257) | 2.70605954 |
| 105 | axoneme assembly (GO:0035082) | 2.70486132 |
| 106 | complement activation, classical pathway (GO:0006958) | 2.70342986 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 2.69296971 |
| 108 | regulation of action potential (GO:0098900) | 2.68082551 |
| 109 | response to pheromone (GO:0019236) | 2.67998423 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.67819344 |
| 111 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.66344556 |
| 112 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.66204865 |
| 113 | aromatic amino acid family catabolic process (GO:0009074) | 2.65979188 |
| 114 | fatty acid transmembrane transport (GO:1902001) | 2.64884952 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64334013 |
| 116 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.64244425 |
| 117 | basement membrane organization (GO:0071711) | 2.63405348 |
| 118 | negative regulation of interleukin-6 production (GO:0032715) | 2.63022080 |
| 119 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.62700113 |
| 120 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.62700113 |
| 121 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.62700113 |
| 122 | regulation of granulocyte differentiation (GO:0030852) | 2.61930144 |
| 123 | signal peptide processing (GO:0006465) | 2.58777339 |
| 124 | positive regulation of cholesterol efflux (GO:0010875) | 2.58744028 |
| 125 | sulfation (GO:0051923) | 2.57680806 |
| 126 | cortical actin cytoskeleton organization (GO:0030866) | 2.56274513 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 2.55620391 |
| 128 | establishment of protein localization to Golgi (GO:0072600) | 2.55264197 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55177381 |
| 130 | negative regulation of cell killing (GO:0031342) | 2.55177381 |
| 131 | ruffle organization (GO:0031529) | 2.52801377 |
| 132 | regulation of skeletal muscle contraction (GO:0014819) | 2.52770825 |
| 133 | glycosphingolipid catabolic process (GO:0046479) | 2.52114750 |
| 134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51951125 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.51224680 |
| 136 | membrane invagination (GO:0010324) | 2.51132003 |
| 137 | oligosaccharide catabolic process (GO:0009313) | 2.50775511 |
| 138 | negative regulation of bone remodeling (GO:0046851) | 2.49404957 |
| 139 | coenzyme catabolic process (GO:0009109) | 2.46099145 |
| 140 | retinal cone cell development (GO:0046549) | 2.45274452 |
| 141 | regulation of glucokinase activity (GO:0033131) | 2.45246187 |
| 142 | regulation of hexokinase activity (GO:1903299) | 2.45246187 |
| 143 | cortical cytoskeleton organization (GO:0030865) | 2.44832950 |
| 144 | regulation of sequestering of triglyceride (GO:0010889) | 2.44623648 |
| 145 | response to peptidoglycan (GO:0032494) | 2.44587640 |
| 146 | NAD biosynthetic process (GO:0009435) | 2.44512489 |
| 147 | detection of molecule of bacterial origin (GO:0032490) | 2.41981131 |
| 148 | regulation of T cell tolerance induction (GO:0002664) | 2.41187572 |
| 149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.40928213 |
| 150 | positive regulation of macrophage cytokine production (GO:0060907) | 2.38019841 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.37960267 |
| 152 | endothelial cell chemotaxis (GO:0035767) | 2.37510644 |
| 153 | collagen fibril organization (GO:0030199) | 2.37223730 |
| 154 | response to fluid shear stress (GO:0034405) | 2.36406306 |
| 155 | myofibril assembly (GO:0030239) | 2.35736058 |
| 156 | iron ion import (GO:0097286) | 2.35553608 |
| 157 | cellular response to sterol (GO:0036315) | 2.35521468 |
| 158 | aromatic amino acid family metabolic process (GO:0009072) | 2.34581557 |
| 159 | startle response (GO:0001964) | 2.34329313 |
| 160 | positive regulation of phagocytosis (GO:0050766) | 2.34199148 |
| 161 | cornea development in camera-type eye (GO:0061303) | 2.33478725 |
| 162 | piRNA metabolic process (GO:0034587) | 2.32744703 |
| 163 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.32172452 |
| 164 | cellular response to interleukin-6 (GO:0071354) | 2.31949744 |
| 165 | lysosome organization (GO:0007040) | 2.31863607 |
| 166 | lytic vacuole organization (GO:0080171) | 2.31863607 |
| 167 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.31519852 |
| 168 | kidney morphogenesis (GO:0060993) | 2.31497760 |
| 169 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.31032624 |
| 170 | cilium morphogenesis (GO:0060271) | 2.30493386 |
| 171 | positive regulation of fatty acid oxidation (GO:0046321) | 2.29294345 |
| 172 | epithelial cilium movement (GO:0003351) | 2.29250020 |
| 173 | positive regulation of fatty acid transport (GO:2000193) | 2.29060680 |
| 174 | extracellular fibril organization (GO:0043206) | 2.28876968 |
| 175 | regulation of platelet activation (GO:0010543) | 2.28474688 |
| 176 | action potential (GO:0001508) | 2.28353676 |
| 177 | negative regulation of protein localization to cell surface (GO:2000009) | 2.27252135 |
| 178 | cilium movement (GO:0003341) | 2.27129482 |
| 179 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.26437995 |
| 180 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.25732999 |
| 181 | neuronal action potential propagation (GO:0019227) | 2.25660643 |
| 182 | cilium organization (GO:0044782) | 2.25570539 |
| 183 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.25538916 |
| 184 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.25513634 |
| 185 | platelet dense granule organization (GO:0060155) | 2.25375326 |
| 186 | renal tubule morphogenesis (GO:0061333) | 2.24600193 |
| 187 | macrophage differentiation (GO:0030225) | 2.24299673 |
| 188 | limb development (GO:0060173) | 2.23520381 |
| 189 | appendage development (GO:0048736) | 2.23520381 |
| 190 | regulation of pigment cell differentiation (GO:0050932) | 2.22559987 |
| 191 | positive regulation of action potential (GO:0045760) | 2.22467822 |
| 192 | positive regulation of glycolytic process (GO:0045821) | 2.21394309 |
| 193 | nephron tubule morphogenesis (GO:0072078) | 2.20172022 |
| 194 | nephron epithelium morphogenesis (GO:0072088) | 2.20172022 |
| 195 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.20062718 |
| 196 | cilium assembly (GO:0042384) | 2.19452837 |
| 197 | protein polyglutamylation (GO:0018095) | 2.17527165 |
| 198 | positive regulation of developmental pigmentation (GO:0048087) | 2.16514622 |
| 199 | L-methionine biosynthetic process (GO:0071265) | 2.15511292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.53353442 |
| 2 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.54817625 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.29257555 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27960095 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03268878 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99778622 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.97498863 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.91169787 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57702929 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.54949474 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.47075513 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47017472 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42958685 |
| 14 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.31600026 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.30069817 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28754676 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25495008 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24589930 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.20381437 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17458510 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17287653 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13073371 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00517527 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99770109 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98282861 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97696315 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.95243806 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94246477 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93471939 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.91657931 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87569951 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86162432 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84597738 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83869729 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83836358 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82787664 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79481720 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78540332 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77062356 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.76729507 |
| 41 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.75988483 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74889566 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71816688 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69811856 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66925497 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66758650 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62411248 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62310686 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62085724 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62020697 |
| 51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.60409990 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57941229 |
| 53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56783280 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55764462 |
| 55 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.55714717 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53154127 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52782998 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51693865 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51039568 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51039568 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50763229 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50486853 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49630002 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.48656749 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48656749 |
| 66 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.48343335 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45051584 |
| 68 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44558851 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44459840 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44060477 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40625275 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.40005934 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39805319 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39191506 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37296186 |
| 76 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36958677 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36196166 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36126079 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35694600 |
| 80 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34861462 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34582807 |
| 82 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34442665 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34332228 |
| 84 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33888198 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31704850 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29663861 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29404310 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27726285 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26727262 |
| 90 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26079140 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25734807 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25631566 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25591175 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25497765 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25079351 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24915102 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23507319 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23303175 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23303175 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22743318 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22236121 |
| 102 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21825988 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21477078 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19079127 |
| 105 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18852851 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18755045 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18527606 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17924305 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17810076 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16560170 |
| 111 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16361333 |
| 112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16219048 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16011746 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15784229 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14703480 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13691441 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13132336 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12230115 |
| 119 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11994785 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10963702 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10597799 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10476513 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10368401 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09923009 |
| 125 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.09267124 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08520485 |
| 127 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08412517 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08382744 |
| 129 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08277512 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05075990 |
| 131 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04072510 |
| 132 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03638552 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03517734 |
| 134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03154555 |
| 135 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.02835131 |
| 136 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02103073 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01974657 |
| 138 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00795754 |
| 139 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00511527 |
| 140 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00381421 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99990726 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99644657 |
| 143 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99377663 |
| 144 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99077227 |
| 145 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98401632 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98375550 |
| 147 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98262032 |
| 148 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98130406 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96964245 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96964245 |
| 151 | * GBX2_23144817_ChIP-Seq_PC3_Human | 0.95252321 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94850434 |
| 153 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93783909 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93765843 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93761813 |
| 156 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91608154 |
| 157 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91396572 |
| 158 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91313256 |
| 159 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89794787 |
| 160 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88089964 |
| 161 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87905231 |
| 162 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86111082 |
| 163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86045072 |
| 164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85683726 |
| 165 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85635545 |
| 166 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83938387 |
| 167 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83608602 |
| 168 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83489343 |
| 169 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82170079 |
| 170 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81740276 |
| 171 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81266071 |
| 172 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81266071 |
| 173 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.80819139 |
| 174 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80008822 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79698736 |
| 176 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79528567 |
| 177 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78991623 |
| 178 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78464547 |
| 179 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76809730 |
| 180 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.75197301 |
| 181 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75037210 |
| 182 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74910726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.59363158 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.93588815 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.81593261 |
| 4 | MP0003646_muscle_fatigue | 3.71397999 |
| 5 | MP0006082_CNS_inflammation | 3.17640864 |
| 6 | MP0003195_calcinosis | 3.15045596 |
| 7 | MP0005275_abnormal_skin_tensile | 3.04744725 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.92540199 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.87170074 |
| 10 | MP0003690_abnormal_glial_cell | 2.38674153 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.36381801 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.35637768 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.29042238 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.28215644 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.27772898 |
| 16 | MP0002419_abnormal_innate_immunity | 2.27266295 |
| 17 | MP0005670_abnormal_white_adipose | 2.23427475 |
| 18 | MP0003279_aneurysm | 2.22269186 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.22049789 |
| 20 | MP0009046_muscle_twitch | 2.21087028 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.14481668 |
| 22 | MP0003075_altered_response_to | 2.14425491 |
| 23 | MP0003436_decreased_susceptibility_to | 2.14090025 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.11801305 |
| 25 | MP0009840_abnormal_foam_cell | 2.07900185 |
| 26 | MP0002876_abnormal_thyroid_physiology | 2.04244168 |
| 27 | MP0004215_abnormal_myocardial_fiber | 2.04166100 |
| 28 | MP0003045_fibrosis | 2.03281403 |
| 29 | MP0003724_increased_susceptibility_to | 2.02265614 |
| 30 | MP0000343_altered_response_to | 2.00031936 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.99000650 |
| 32 | MP0003303_peritoneal_inflammation | 1.98032350 |
| 33 | MP0003252_abnormal_bile_duct | 1.92025797 |
| 34 | MP0005671_abnormal_response_to | 1.91914158 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.90126816 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.89286149 |
| 37 | MP0008004_abnormal_stomach_pH | 1.83116007 |
| 38 | MP0009745_abnormal_behavioral_response | 1.80702524 |
| 39 | MP0003136_yellow_coat_color | 1.77568028 |
| 40 | MP0002736_abnormal_nociception_after | 1.73235591 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.71408157 |
| 42 | MP0003828_pulmonary_edema | 1.70744373 |
| 43 | MP0001851_eye_inflammation | 1.67997271 |
| 44 | MP0004043_abnormal_pH_regulation | 1.65296923 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.64673227 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.63956566 |
| 47 | MP0002272_abnormal_nervous_system | 1.60550833 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.59925396 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.54694177 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.53469576 |
| 51 | MP0004272_abnormal_basement_membrane | 1.53450582 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.53264131 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.52400311 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.52336656 |
| 55 | MP0005171_absent_coat_pigmentation | 1.52071594 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.51191272 |
| 57 | MP0008872_abnormal_physiological_respon | 1.49156508 |
| 58 | MP0000230_abnormal_systemic_arterial | 1.48615964 |
| 59 | MP0001486_abnormal_startle_reflex | 1.48319891 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.47703222 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.47633544 |
| 62 | MP0005253_abnormal_eye_physiology | 1.45937939 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.43583251 |
| 64 | MP0002102_abnormal_ear_morphology | 1.42805195 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.42673107 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.42194266 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.41637488 |
| 68 | MP0004924_abnormal_behavior | 1.41637488 |
| 69 | MP0004142_abnormal_muscle_tone | 1.39884844 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.39861653 |
| 71 | MP0005390_skeleton_phenotype | 1.38893893 |
| 72 | MP0000427_abnormal_hair_cycle | 1.35773988 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.35066703 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.34749015 |
| 75 | MP0002254_reproductive_system_inflammat | 1.33997252 |
| 76 | MP0001984_abnormal_olfaction | 1.33396194 |
| 77 | MP0002166_altered_tumor_susceptibility | 1.33238474 |
| 78 | MP0004510_myositis | 1.33057860 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32394170 |
| 80 | MP0001800_abnormal_humoral_immune | 1.30812468 |
| 81 | MP0001915_intracranial_hemorrhage | 1.29877917 |
| 82 | MP0005166_decreased_susceptibility_to | 1.29680202 |
| 83 | MP0004883_abnormal_blood_vessel | 1.29581076 |
| 84 | MP0001790_abnormal_immune_system | 1.29374157 |
| 85 | MP0005387_immune_system_phenotype | 1.29374157 |
| 86 | MP0000372_irregular_coat_pigmentation | 1.29363525 |
| 87 | MP0002396_abnormal_hematopoietic_system | 1.29091974 |
| 88 | MP0002928_abnormal_bile_duct | 1.27643070 |
| 89 | MP0008877_abnormal_DNA_methylation | 1.26612842 |
| 90 | MP0001853_heart_inflammation | 1.25092563 |
| 91 | MP0004885_abnormal_endolymph | 1.24153596 |
| 92 | MP0005025_abnormal_response_to | 1.23797164 |
| 93 | MP0002723_abnormal_immune_serum | 1.23673854 |
| 94 | MP0002933_joint_inflammation | 1.23232636 |
| 95 | MP0004130_abnormal_muscle_cell | 1.22871724 |
| 96 | MP0002090_abnormal_vision | 1.22072730 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 1.21062638 |
| 98 | MP0002572_abnormal_emotion/affect_behav | 1.21003354 |
| 99 | MP0005620_abnormal_muscle_contractility | 1.19714065 |
| 100 | MP0000249_abnormal_blood_vessel | 1.19432324 |
| 101 | MP0002067_abnormal_sensory_capabilities | 1.18750948 |
| 102 | MP0004085_abnormal_heartbeat | 1.17236098 |
| 103 | MP0005174_abnormal_tail_pigmentation | 1.16742662 |
| 104 | MP0005023_abnormal_wound_healing | 1.16720859 |
| 105 | MP0005666_abnormal_adipose_tissue | 1.16652674 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.16499620 |
| 107 | MP0002735_abnormal_chemical_nociception | 1.16491995 |
| 108 | MP0002064_seizures | 1.13137950 |
| 109 | MP0002557_abnormal_social/conspecific_i | 1.13027148 |
| 110 | MP0005257_abnormal_intraocular_pressure | 1.12239032 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 1.11707591 |
| 112 | MP0000569_abnormal_digit_pigmentation | 1.11612238 |
| 113 | MP0001958_emphysema | 1.10825662 |
| 114 | MP0003137_abnormal_impulse_conducting | 1.10798561 |
| 115 | MP0001970_abnormal_pain_threshold | 1.09948299 |
| 116 | MP0001819_abnormal_immune_cell | 1.09174382 |
| 117 | MP0008469_abnormal_protein_level | 1.08418203 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 1.08394652 |
| 119 | MP0010329_abnormal_lipoprotein_level | 1.07238135 |
| 120 | MP0002420_abnormal_adaptive_immunity | 1.07185650 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 1.05509514 |
| 122 | MP0000538_abnormal_urinary_bladder | 1.04348857 |
| 123 | MP0002733_abnormal_thermal_nociception | 1.03638528 |
| 124 | MP0000751_myopathy | 1.03000241 |
| 125 | MP0002108_abnormal_muscle_morphology | 1.02252520 |
| 126 | MP0005508_abnormal_skeleton_morphology | 1.00736090 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 1.00670093 |
| 128 | MP0003011_delayed_dark_adaptation | 1.00034377 |
| 129 | MP0002060_abnormal_skin_morphology | 0.99143020 |
| 130 | MP0003635_abnormal_synaptic_transmissio | 0.98238517 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.97305062 |
| 132 | MP0004147_increased_porphyrin_level | 0.97088026 |
| 133 | MP0003880_abnormal_central_pattern | 0.92823474 |
| 134 | MP0000685_abnormal_immune_system | 0.92807426 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.91736000 |
| 136 | MP0005165_increased_susceptibility_to | 0.91249588 |
| 137 | MP0003283_abnormal_digestive_organ | 0.91069336 |
| 138 | MP0000920_abnormal_myelination | 0.91030462 |
| 139 | MP0002405_respiratory_system_inflammati | 0.90988287 |
| 140 | MP0002006_tumorigenesis | 0.90471839 |
| 141 | MP0002063_abnormal_learning/memory/cond | 0.90228873 |
| 142 | MP0002168_other_aberrant_phenotype | 0.88106472 |
| 143 | MP0003633_abnormal_nervous_system | 0.87662131 |
| 144 | MP0001542_abnormal_bone_strength | 0.86814570 |
| 145 | MP0002160_abnormal_reproductive_system | 0.85484796 |
| 146 | MP0005164_abnormal_response_to | 0.85286576 |
| 147 | MP0005595_abnormal_vascular_smooth | 0.84194672 |
| 148 | MP0004484_altered_response_of | 0.83927740 |
| 149 | MP0002971_abnormal_brown_adipose | 0.83841881 |
| 150 | MP0005410_abnormal_fertilization | 0.83636348 |
| 151 | MP0002938_white_spotting | 0.82987181 |
| 152 | MP0000631_abnormal_neuroendocrine_gland | 0.80679401 |
| 153 | MP0004742_abnormal_vestibular_system | 0.80530614 |
| 154 | MP0006054_spinal_hemorrhage | 0.80348738 |
| 155 | MP0005448_abnormal_energy_balance | 0.80216693 |
| 156 | MP0005197_abnormal_uvea_morphology | 0.79760369 |
| 157 | MP0005266_abnormal_metabolism | 0.79399999 |
| 158 | MP0009384_cardiac_valve_regurgitation | 0.79191401 |
| 159 | MP0005369_muscle_phenotype | 0.78949764 |
| 160 | MP0000013_abnormal_adipose_tissue | 0.78442916 |
| 161 | MP0003448_altered_tumor_morphology | 0.78117908 |
| 162 | MP0000383_abnormal_hair_follicle | 0.78047142 |
| 163 | MP0009278_abnormal_bone_marrow | 0.77618852 |
| 164 | MP0000749_muscle_degeneration | 0.76385325 |
| 165 | MP0009763_increased_sensitivity_to | 0.76317209 |
| 166 | MP0003795_abnormal_bone_structure | 0.73932785 |
| 167 | MP0003091_abnormal_cell_migration | 0.73512052 |
| 168 | MP0002136_abnormal_kidney_physiology | 0.72651198 |
| 169 | MP0005195_abnormal_posterior_eye | 0.72008002 |
| 170 | MP0002734_abnormal_mechanical_nocicepti | 0.71727019 |
| 171 | MP0005332_abnormal_amino_acid | 0.71558003 |
| 172 | MP0001879_abnormal_lymphatic_vessel | 0.71150020 |
| 173 | MP0005389_reproductive_system_phenotype | 0.71070355 |
| 174 | MP0000716_abnormal_immune_system | 0.70953812 |
| 175 | MP0001661_extended_life_span | 0.70840633 |
| 176 | MP0001963_abnormal_hearing_physiology | 0.70637121 |
| 177 | MP0005085_abnormal_gallbladder_physiolo | 0.69082016 |
| 178 | MP0003879_abnormal_hair_cell | 0.69008856 |
| 179 | MP0002135_abnormal_kidney_morphology | 0.68142985 |
| 180 | MP0005375_adipose_tissue_phenotype | 0.67979437 |
| 181 | MP0001614_abnormal_blood_vessel | 0.67652320 |
| 182 | MP0000689_abnormal_spleen_morphology | 0.67447457 |
| 183 | MP0002128_abnormal_blood_circulation | 0.67017522 |
| 184 | MP0000609_abnormal_liver_physiology | 0.64823055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glomerulonephritis (HP:0000099) | 9.14698170 |
| 2 | Complement deficiency (HP:0004431) | 7.67471796 |
| 3 | Abnormality of complement system (HP:0005339) | 6.31759027 |
| 4 | Cerebral aneurysm (HP:0004944) | 5.74492963 |
| 5 | Arterial tortuosity (HP:0005116) | 5.71593310 |
| 6 | Vascular tortuosity (HP:0004948) | 5.15312601 |
| 7 | Nephritis (HP:0000123) | 5.12912928 |
| 8 | Aortic aneurysm (HP:0004942) | 4.55857847 |
| 9 | Hyperventilation (HP:0002883) | 4.48341615 |
| 10 | Pancreatic cysts (HP:0001737) | 4.35338764 |
| 11 | Aortic dissection (HP:0002647) | 4.33831604 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.10633707 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.10633707 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.10633707 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.91635377 |
| 16 | Genetic anticipation (HP:0003743) | 3.91257848 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 3.88169963 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.87651282 |
| 19 | Hematochezia (HP:0002573) | 3.87120513 |
| 20 | Retinal atrophy (HP:0001105) | 3.84925697 |
| 21 | True hermaphroditism (HP:0010459) | 3.67844375 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.67375523 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.66572605 |
| 24 | Striae distensae (HP:0001065) | 3.64928307 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.63490532 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.55061060 |
| 27 | Nephronophthisis (HP:0000090) | 3.54184639 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.52963368 |
| 29 | Disproportionate tall stature (HP:0001519) | 3.51796485 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.51512077 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.49459112 |
| 32 | Attenuation of retinal blood vessels (HP:0007843) | 3.46761360 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 3.44826069 |
| 34 | Molar tooth sign on MRI (HP:0002419) | 3.44826069 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 3.40944197 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.26981475 |
| 37 | Mitral valve prolapse (HP:0001634) | 3.25481443 |
| 38 | Keratoconus (HP:0000563) | 3.24537795 |
| 39 | Increased corneal curvature (HP:0100692) | 3.24537795 |
| 40 | Eczematoid dermatitis (HP:0000976) | 3.15761824 |
| 41 | Type II lissencephaly (HP:0007260) | 3.10271287 |
| 42 | Mutism (HP:0002300) | 3.07342624 |
| 43 | Axonal loss (HP:0003447) | 3.03896938 |
| 44 | Soft skin (HP:0000977) | 3.00388492 |
| 45 | Spondylolisthesis (HP:0003302) | 3.00386395 |
| 46 | Fair hair (HP:0002286) | 2.96536020 |
| 47 | Urethral obstruction (HP:0000796) | 2.94591001 |
| 48 | Medial flaring of the eyebrow (HP:0010747) | 2.93947057 |
| 49 | Clumsiness (HP:0002312) | 2.93828870 |
| 50 | Disinhibition (HP:0000734) | 2.91845235 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.91322816 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.91322816 |
| 53 | Renal cortical cysts (HP:0000803) | 2.87482640 |
| 54 | Large for gestational age (HP:0001520) | 2.83812511 |
| 55 | Inability to walk (HP:0002540) | 2.83808110 |
| 56 | Tubular atrophy (HP:0000092) | 2.82728699 |
| 57 | Cystic liver disease (HP:0006706) | 2.82538485 |
| 58 | Chronic hepatic failure (HP:0100626) | 2.82520275 |
| 59 | Congenital sensorineural hearing impairment (HP:0008527) | 2.82002925 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81353423 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81353423 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81353423 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81314537 |
| 64 | Broad metatarsal (HP:0001783) | 2.79010173 |
| 65 | Febrile seizures (HP:0002373) | 2.75077083 |
| 66 | Abnormal drinking behavior (HP:0030082) | 2.73167642 |
| 67 | Polydipsia (HP:0001959) | 2.73167642 |
| 68 | Protruding tongue (HP:0010808) | 2.70587562 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.66087721 |
| 70 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64332680 |
| 71 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.59681962 |
| 72 | Progressive visual loss (HP:0000529) | 2.59217632 |
| 73 | Protrusio acetabuli (HP:0003179) | 2.59112903 |
| 74 | Absent speech (HP:0001344) | 2.57994388 |
| 75 | Decreased circulating renin level (HP:0003351) | 2.57418481 |
| 76 | Premature rupture of membranes (HP:0001788) | 2.56389489 |
| 77 | Decreased central vision (HP:0007663) | 2.51771396 |
| 78 | Cerebellar dysplasia (HP:0007033) | 2.51479226 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.50424010 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 2.49176595 |
| 81 | Hyperalaninemia (HP:0003348) | 2.49176595 |
| 82 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49176595 |
| 83 | Osteolytic defects of the hand bones (HP:0009699) | 2.45935247 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45935247 |
| 85 | Broad-based gait (HP:0002136) | 2.40388415 |
| 86 | Thick nail (HP:0001805) | 2.39386611 |
| 87 | Congenital hepatic fibrosis (HP:0002612) | 2.37974610 |
| 88 | Myocardial infarction (HP:0001658) | 2.36218162 |
| 89 | Gait imbalance (HP:0002141) | 2.34609676 |
| 90 | Progressive inability to walk (HP:0002505) | 2.32212654 |
| 91 | Chronic diarrhea (HP:0002028) | 2.30692068 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29056528 |
| 93 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.27979597 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 2.26386797 |
| 95 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.26336695 |
| 96 | Polyuria (HP:0000103) | 2.25072648 |
| 97 | Focal seizures (HP:0007359) | 2.24002725 |
| 98 | Congenital primary aphakia (HP:0007707) | 2.23847033 |
| 99 | Furrowed tongue (HP:0000221) | 2.20638241 |
| 100 | Absent/shortened dynein arms (HP:0200106) | 2.19913310 |
| 101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19913310 |
| 102 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19338823 |
| 103 | Shallow orbits (HP:0000586) | 2.18264095 |
| 104 | Hypoplastic ischia (HP:0003175) | 2.17944303 |
| 105 | Calf muscle hypertrophy (HP:0008981) | 2.17270579 |
| 106 | Pathologic fracture (HP:0002756) | 2.14298582 |
| 107 | Thyroid-stimulating hormone excess (HP:0002925) | 2.13409015 |
| 108 | Dialeptic seizures (HP:0011146) | 2.13174503 |
| 109 | Peripheral demyelination (HP:0011096) | 2.10420013 |
| 110 | Aneurysm (HP:0002617) | 2.10121651 |
| 111 | Amyloidosis (HP:0011034) | 2.07780408 |
| 112 | Vertebral compression fractures (HP:0002953) | 2.07767707 |
| 113 | Arnold-Chiari malformation (HP:0002308) | 2.06860309 |
| 114 | Atrial fibrillation (HP:0005110) | 2.06649351 |
| 115 | Left ventricular hypertrophy (HP:0001712) | 2.05965157 |
| 116 | Congenital, generalized hypertrichosis (HP:0004540) | 2.04358044 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.03951271 |
| 118 | Thyroiditis (HP:0100646) | 2.03343582 |
| 119 | Prolonged QT interval (HP:0001657) | 2.03117532 |
| 120 | Bulbous nose (HP:0000414) | 2.02857508 |
| 121 | Abnormal ciliary motility (HP:0012262) | 2.01669481 |
| 122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.01221774 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 2.00494320 |
| 124 | Cardiomegaly (HP:0001640) | 2.00270272 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 10.6720539 |
| 126 | Exotropia (HP:0000577) | 1.99565746 |
| 127 | Abnormality of the ischium (HP:0003174) | 1.99423828 |
| 128 | Recurrent skin infections (HP:0001581) | 1.99241679 |
| 129 | Mitral stenosis (HP:0001718) | 1.99123277 |
| 130 | Hemiparesis (HP:0001269) | 1.99093537 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97941233 |
| 132 | Widely spaced teeth (HP:0000687) | 1.97790464 |
| 133 | Tubulointerstitial fibrosis (HP:0005576) | 1.97689525 |
| 134 | Colitis (HP:0002583) | 1.96012000 |
| 135 | Tubulointerstitial abnormality (HP:0001969) | 1.95807715 |
| 136 | Agnosia (HP:0010524) | 1.94264294 |
| 137 | Focal motor seizures (HP:0011153) | 1.92987382 |
| 138 | Upper motor neuron abnormality (HP:0002127) | 1.92534209 |
| 139 | Sclerocornea (HP:0000647) | 1.92522847 |
| 140 | Hypothermia (HP:0002045) | 1.91791511 |
| 141 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91316896 |
| 142 | Increased CSF protein (HP:0002922) | 1.90771123 |
| 143 | Stomach cancer (HP:0012126) | 1.90674027 |
| 144 | Gingivitis (HP:0000230) | 1.90320210 |
| 145 | Primary atrial arrhythmia (HP:0001692) | 1.90069838 |
| 146 | Genital tract atresia (HP:0001827) | 1.89063549 |
| 147 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87544803 |
| 148 | Abnormal urine output (HP:0012590) | 1.87135551 |
| 149 | Follicular hyperkeratosis (HP:0007502) | 1.85752957 |
| 150 | Postaxial foot polydactyly (HP:0001830) | 1.85319077 |
| 151 | Ketosis (HP:0001946) | 1.84420138 |
| 152 | Hyperkalemia (HP:0002153) | 1.83387048 |
| 153 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82706221 |
| 154 | Ketoacidosis (HP:0001993) | 1.82537647 |
| 155 | Anencephaly (HP:0002323) | 1.82395377 |
| 156 | Blue sclerae (HP:0000592) | 1.82277880 |
| 157 | Prominent supraorbital ridges (HP:0000336) | 1.80569001 |
| 158 | Syncope (HP:0001279) | 1.80424033 |
| 159 | Chorioretinal atrophy (HP:0000533) | 1.79934247 |
| 160 | Joint stiffness (HP:0001387) | 1.78382873 |
| 161 | Ulnar claw (HP:0001178) | 1.78200987 |
| 162 | Short foot (HP:0001773) | 1.77488875 |
| 163 | Vaginal atresia (HP:0000148) | 1.77199212 |
| 164 | Absence seizures (HP:0002121) | 1.76651154 |
| 165 | Facial diplegia (HP:0001349) | 1.76068628 |
| 166 | Central scotoma (HP:0000603) | 1.75450718 |
| 167 | Bundle branch block (HP:0011710) | 1.75312230 |
| 168 | Lissencephaly (HP:0001339) | 1.75209987 |
| 169 | Abnormality of potassium homeostasis (HP:0011042) | 1.75081354 |
| 170 | Atonic seizures (HP:0010819) | 1.74653763 |
| 171 | Bladder diverticulum (HP:0000015) | 1.74227642 |
| 172 | Spinal muscular atrophy (HP:0007269) | 1.73526176 |
| 173 | Camptodactyly of toe (HP:0001836) | 1.73371709 |
| 174 | Bicuspid aortic valve (HP:0001647) | 1.73163118 |
| 175 | Neuronal loss in central nervous system (HP:0002529) | 1.71145363 |
| 176 | Progressive neurologic deterioration (HP:0002344) | 1.70869609 |
| 177 | Joint laxity (HP:0001388) | 1.69498974 |
| 178 | Periodontitis (HP:0000704) | 1.65374544 |
| 179 | Bone pain (HP:0002653) | 1.63867756 |
| 180 | Joint hemorrhage (HP:0005261) | 1.62243646 |
| 181 | Orthostatic hypotension (HP:0001278) | 1.61737992 |
| 182 | Polygenic inheritance (HP:0010982) | 1.59460068 |
| 183 | Bone cyst (HP:0012062) | 1.59011315 |
| 184 | Abnormality of the lumbar spine (HP:0100712) | 1.58555832 |
| 185 | Inappropriate behavior (HP:0000719) | 1.58199635 |
| 186 | Ovoid vertebral bodies (HP:0003300) | 1.56918625 |
| 187 | Eosinophilia (HP:0001880) | 1.56313635 |
| 188 | Ankle contracture (HP:0006466) | 1.55778474 |
| 189 | Abnormality of macrophages (HP:0004311) | 1.54973793 |
| 190 | Thoracic kyphosis (HP:0002942) | 1.53031732 |
| 191 | Cervical subluxation (HP:0003308) | 1.52851029 |
| 192 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.51432144 |
| 193 | Coarse hair (HP:0002208) | 1.50389753 |
| 194 | Broad ribs (HP:0000885) | 1.49294724 |
| 195 | Thickened calvaria (HP:0002684) | 1.48265246 |
| 196 | Pulmonary artery stenosis (HP:0004415) | 1.45903537 |
| 197 | Hydroxyprolinuria (HP:0003080) | 1.44668467 |
| 198 | Abnormality of proline metabolism (HP:0010907) | 1.44668467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 8.40173475 |
| 2 | GRK7 | 4.33320757 |
| 3 | MAPK15 | 3.93216207 |
| 4 | CAMK1D | 3.51148859 |
| 5 | PINK1 | 2.95449271 |
| 6 | CAMK1G | 2.85545973 |
| 7 | BMPR1B | 2.84623831 |
| 8 | ACVR1B | 2.73868288 |
| 9 | CSF1R | 2.65438996 |
| 10 | TYK2 | 2.36392609 |
| 11 | IRAK4 | 2.23097349 |
| 12 | BLK | 2.21770964 |
| 13 | OBSCN | 2.12503814 |
| 14 | GRK1 | 2.10987983 |
| 15 | MAP4K2 | 2.04501602 |
| 16 | MAPK13 | 1.87736763 |
| 17 | TAOK3 | 1.83893508 |
| 18 | WNK3 | 1.68783706 |
| 19 | JAK1 | 1.60099468 |
| 20 | NUAK1 | 1.58637513 |
| 21 | CASK | 1.56917964 |
| 22 | ADRBK2 | 1.55411533 |
| 23 | WNK4 | 1.50603972 |
| 24 | INSRR | 1.50266837 |
| 25 | ITK | 1.49791380 |
| 26 | NEK9 | 1.42575221 |
| 27 | ADRBK1 | 1.40818739 |
| 28 | PDK2 | 1.39537971 |
| 29 | NTRK3 | 1.39489104 |
| 30 | STK38L | 1.37742524 |
| 31 | MAPK12 | 1.35620590 |
| 32 | RIPK4 | 1.35500147 |
| 33 | MARK1 | 1.35431870 |
| 34 | MAP3K4 | 1.35035243 |
| 35 | PAK4 | 1.34961408 |
| 36 | CAMKK2 | 1.34222106 |
| 37 | ERN1 | 1.34021496 |
| 38 | ZAK | 1.33596515 |
| 39 | DAPK2 | 1.33056968 |
| 40 | PAK3 | 1.31431553 |
| 41 | TIE1 | 1.26328000 |
| 42 | TGFBR1 | 1.26313972 |
| 43 | AKT3 | 1.22076819 |
| 44 | MUSK | 1.22001356 |
| 45 | MYLK | 1.21376139 |
| 46 | OXSR1 | 1.19846267 |
| 47 | TNIK | 1.19465217 |
| 48 | STK39 | 1.19449475 |
| 49 | EPHB1 | 1.17138783 |
| 50 | LATS1 | 1.12157942 |
| 51 | PRKCE | 1.10991119 |
| 52 | PHKG1 | 1.08161946 |
| 53 | PHKG2 | 1.08161946 |
| 54 | HCK | 1.04242004 |
| 55 | CSK | 1.03410244 |
| 56 | TBK1 | 1.03132298 |
| 57 | ZAP70 | 1.02731772 |
| 58 | PNCK | 1.02494657 |
| 59 | NLK | 1.00705718 |
| 60 | MAPK7 | 0.99270246 |
| 61 | PTK2B | 0.98682874 |
| 62 | STK10 | 0.96931014 |
| 63 | DMPK | 0.94031696 |
| 64 | MAP3K10 | 0.93854475 |
| 65 | CAMK4 | 0.93737290 |
| 66 | MKNK2 | 0.92875453 |
| 67 | PAK2 | 0.91297083 |
| 68 | SIK1 | 0.88788534 |
| 69 | PRKCG | 0.87896452 |
| 70 | MAP2K3 | 0.87798907 |
| 71 | EEF2K | 0.85993286 |
| 72 | CDK3 | 0.85221771 |
| 73 | LYN | 0.84628700 |
| 74 | CLK1 | 0.83754634 |
| 75 | SIK2 | 0.82863588 |
| 76 | PIK3CG | 0.81488428 |
| 77 | TRIB3 | 0.81229308 |
| 78 | TEC | 0.80479447 |
| 79 | CAMKK1 | 0.77310684 |
| 80 | IKBKB | 0.77294896 |
| 81 | JAK2 | 0.77225611 |
| 82 | IGF1R | 0.76232685 |
| 83 | MAP3K14 | 0.75775663 |
| 84 | CAMK2A | 0.75632716 |
| 85 | KIT | 0.75550040 |
| 86 | MOS | 0.73535741 |
| 87 | PRKAA2 | 0.72737399 |
| 88 | FER | 0.72169703 |
| 89 | IRAK3 | 0.71793182 |
| 90 | TSSK6 | 0.70025677 |
| 91 | TTN | 0.68991426 |
| 92 | MAP4K1 | 0.65795808 |
| 93 | LCK | 0.64690383 |
| 94 | MATK | 0.64081391 |
| 95 | PLK2 | 0.63800430 |
| 96 | TLK1 | 0.63774157 |
| 97 | TXK | 0.63489886 |
| 98 | MAPKAPK2 | 0.61205722 |
| 99 | MAPKAPK3 | 0.61022646 |
| 100 | VRK1 | 0.60949561 |
| 101 | MAPKAPK5 | 0.60699658 |
| 102 | MAP3K6 | 0.60269143 |
| 103 | IRAK1 | 0.59597762 |
| 104 | PRKAA1 | 0.59379444 |
| 105 | SCYL2 | 0.59319026 |
| 106 | PKN1 | 0.59169176 |
| 107 | PTK6 | 0.58765174 |
| 108 | CDK6 | 0.58317985 |
| 109 | PRKG1 | 0.57845309 |
| 110 | IRAK2 | 0.57754599 |
| 111 | FES | 0.57444546 |
| 112 | SGK3 | 0.56419388 |
| 113 | GSK3A | 0.56046620 |
| 114 | FGFR3 | 0.55308809 |
| 115 | PRKACA | 0.55247757 |
| 116 | MAP2K7 | 0.53836364 |
| 117 | TRPM7 | 0.53702188 |
| 118 | PRKD1 | 0.52887265 |
| 119 | PDGFRA | 0.52237282 |
| 120 | BTK | 0.52204443 |
| 121 | MAP2K1 | 0.51511612 |
| 122 | STK11 | 0.51351897 |
| 123 | SGK223 | 0.51134997 |
| 124 | SGK494 | 0.51134997 |
| 125 | MARK3 | 0.49898145 |
| 126 | FRK | 0.49289423 |
| 127 | RIPK1 | 0.48135928 |
| 128 | GRK5 | 0.47507999 |
| 129 | MAP3K13 | 0.47383823 |
| 130 | EIF2AK2 | 0.47316088 |
| 131 | DDR2 | 0.46757038 |
| 132 | SGK2 | 0.46394457 |
| 133 | PDGFRB | 0.45946927 |
| 134 | TNK2 | 0.45715419 |
| 135 | CAMK1 | 0.45604760 |
| 136 | PKN2 | 0.45497780 |
| 137 | PDK1 | 0.45403671 |
| 138 | EGFR | 0.44884397 |
| 139 | MAP2K6 | 0.44773640 |
| 140 | CAMK2D | 0.43844414 |
| 141 | PRKCQ | 0.43694318 |
| 142 | EPHA3 | 0.41672840 |
| 143 | MST1R | 0.40913173 |
| 144 | DYRK2 | 0.40177439 |
| 145 | INSR | 0.40131540 |
| 146 | NTRK2 | 0.38905701 |
| 147 | CSNK1G2 | 0.38677358 |
| 148 | PDPK1 | 0.38092797 |
| 149 | PRKACB | 0.37711621 |
| 150 | PRKCA | 0.37573577 |
| 151 | ROCK1 | 0.37486173 |
| 152 | WNK1 | 0.37412714 |
| 153 | ERBB3 | 0.37315792 |
| 154 | PRKCH | 0.37204040 |
| 155 | PIK3CA | 0.36646454 |
| 156 | DYRK1A | 0.35389528 |
| 157 | MAPK4 | 0.35146563 |
| 158 | PRKACG | 0.35020472 |
| 159 | SYK | 0.34915256 |
| 160 | STK38 | 0.34883243 |
| 161 | RPS6KA2 | 0.34464976 |
| 162 | MAP3K7 | 0.33827150 |
| 163 | ERBB2 | 0.33767931 |
| 164 | STK3 | 0.32559103 |
| 165 | CHUK | 0.32234283 |
| 166 | FGFR2 | 0.31993338 |
| 167 | EPHA4 | 0.30930016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.82051181 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.54429531 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.35953642 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76056552 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.70893359 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.58957290 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.52848673 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48467901 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.44504770 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.41107328 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.31469302 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.26068036 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.24098246 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.19379171 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.13798385 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 2.06699523 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99082670 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.97304110 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94669529 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.93274581 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.92343592 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85076597 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79847204 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77446652 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73367957 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.69972033 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65936653 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.63651083 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.63311136 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56529254 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56308637 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56015586 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51859478 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51536369 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51441703 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46576276 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45883742 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44555801 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41575759 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.37827574 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.35672788 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35084749 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33565881 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.33354090 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32676697 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31521716 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.30856543 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27690396 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27205438 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26606896 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26540504 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.24660162 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 1.23817163 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.23456889 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22321105 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21972675 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20217369 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.20140385 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18536758 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16031620 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11487867 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 1.10734884 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09419468 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 1.06133739 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 1.05790761 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05526497 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04353886 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03916312 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 1.03493398 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01127598 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 1.00127362 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99800313 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.98996566 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.97010620 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89744411 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.88957002 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88077731 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.87482058 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87394658 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.85891082 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85048208 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83935512 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83472433 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81874141 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81698464 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81012092 |
| 87 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80980336 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.80819103 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.80802086 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79801122 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.74917186 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74372884 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.71776304 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71445843 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71319805 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.69940434 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69192403 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68030243 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67325657 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66510939 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66093556 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.64404241 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63968644 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63874680 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63020945 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62112135 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61741894 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61729928 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.61596557 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61235685 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61109774 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59313174 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58993125 |
| 114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58821236 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58614569 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58219087 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57628973 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57492062 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56918940 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56207510 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.54500199 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.54365046 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | 0.54304372 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54107472 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53749773 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53233597 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52978809 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52467769 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52355729 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52093915 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51791538 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51494512 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51091440 |
| 134 | Asthma_Homo sapiens_hsa05310 | 0.49987498 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49871225 |
| 136 | * ABC transporters_Homo sapiens_hsa02010 | 0.49852955 |
| 137 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49361206 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49128206 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48903539 |
| 140 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48472399 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47577149 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46690081 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45153502 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44758895 |
| 145 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44432749 |
| 146 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44267379 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43854482 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43758686 |
| 149 | Apoptosis_Homo sapiens_hsa04210 | 0.43085104 |
| 150 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43026160 |
| 151 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42719984 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.42693202 |
| 153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42059711 |
| 154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41990296 |
| 155 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41857861 |
| 156 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41387253 |
| 157 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41098782 |
| 158 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40993533 |
| 159 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40211488 |
| 160 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39418425 |
| 161 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39278356 |
| 162 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37966505 |
| 163 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37778643 |
| 164 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36447490 |
| 165 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36326388 |
| 166 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35368602 |
| 167 | Glioma_Homo sapiens_hsa05214 | 0.32859258 |
| 168 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32674720 |
| 169 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32427877 |
| 170 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32191636 |
| 171 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31287444 |
| 172 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28577175 |
| 173 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28043153 |
| 174 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27447444 |

